Among EGFR-mutant cases, patients with an increasing trend in T790M quantity from pre- to post-EGFR-TKI displayed superior PFS and OS compared with patients with a decreasing trend.
← all excerpts
Quantification and dynamic monitoring of EGFR T790M in plasma cell-free DNA by digital PCR for prognosis of EGFR-TKI treatment in advanced NSCLC.
1
—
—